Kurm Pharma ApS: Financial statements 2019
CVR: 39181274
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Kurm Pharma ApS (CVR 39181274) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 666,835 and a net result of DKK 506,343 compared with DKK 347,758 the year before. That is an increase of 34.9% compared with the year before. Equity in the 2019 report amounted to DKK 904,101. The solvency ratio was 23.4%.
- Gross Profit
- DKK 666,835
- Profit/Loss
- DKK 506,343
- Equity
- DKK 904,101
- Total Assets
- DKK 3,868,541
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 667 t. | 506 t. | 904 t. | - |
| 2018 | - | 494 t. | 348 t. | 398 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Kurm Pharma ApS has published its annual report for 2018. Gross profit came to DKK 494,249, and the net result was DKK 347,758.
About Kurm Pharma ApS
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033.